<unk>  (EV/DHEA-E), sold under the brand name Gynodian Depot among others, is an injectable combination medication of estradiol<unk>  (EV), an estrogen, and<unk>  enanthate (-E), an androgen, estrogen, and neurosteroid, which is used in menopausal hormone therapy for women. It is provided in the form of 1 mL ampoules containing 4 mg estradiol<unk>  and 200 mg<unk>  enanthate in an oil solution and is administered by intramuscular injection once every 4 to 6 weeks. EV/DHEA-E reportedly has a duration of about 21 days. The medication is available in Europe, Latin America, and Egypt. EV/DHEA-E was developed and marketed by Schering, was first described in the literature in 1972, and was introduced for medical use in April 1975. Estradiol and levels after a single intramuscular injection of Gynodian Depot (4 mg estradiol<unk> , 200 mg<unk>  enanthate in oil) in women.
Estradiol valerate/prasterone enanthate
Estradiol undecylate/norethisterone enanthate
Estradiol enantate/algestone acetophenide
Relugolix/estradiol/norethisterone acetate
Estradiol valerate/norethisterone enantate
Estradiol valerate/testosterone enanthate
Estradiol valerate/methenmadinone caproate
Estradiol/norethisterone acetate